Delivery Order SPE2DR25D2006-SPE2DR26F56SE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,553.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a $19,211.98 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) under a firm fixed price contract. The award was made competitively with no set-aside designation on April 24, 2025, with completion expected by April 25, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) under a firm fixed-price arrangement. The contract, valued at $38,252.15, represents a single delivery order executed on December 2, 2025, with completion scheduled for December 3, 2025. This award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $1,151.04. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) valued at $11,571.36 under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement to support federal medical supply needs, with performance to occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,616.41 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablet) 4 mg in quantities of 30 tablets. This firm fixed-price delivery order, awarded on November 26, 2025, represents a non-set-aside competitive award with an ultimate completion date of November 28, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,288.98 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). The contract, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, carries firm fixed price terms and was competitively awarded without set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $26,055.15. This competitively awarded, firm fixed-price delivery order was issued on December 3, 2025, with an ultimate completion date of December 4, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units. This firm fixed price delivery order, valued at $10,217.96, represents a non-set-aside competitive award with an ultimate completion date of December 4, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56SEDelivery Order
The Defense Logistics Agency awarded a $2,421.15 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed price contract. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-competitive set-aside delivery order. Performance will be executed from the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of medications and medical supplies across multiple therapeutic domains, positioning it as a critical vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/10/25 |